Anticancer online medicine | Millionpharma

POMAHOPE 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 4mg and it belongs to anti-neoplastic drugs Pomahope 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 4mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 4mg Capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi...

POMAHOPE 3MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 3mg and it belongs to anti-neoplastic drugs Pomahope 3mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 3mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 3mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 3mg capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 3mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi...

POMAHOPE 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 2mg and it belongs to anti-neoplastic drugs Pomahope 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 2mg is used by combining with dexamethasone. Pomahope 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activitie...

POMAHOPE 1MG POMAHOPE 1MG DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg capsules is used by combining with dexamethasone. Pomahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological ac...

POMAHOPE 3MG IMMUNE MODULATORY DESCRIPTION Pomalidomide is sold under the brand name Pomahope 3mg and it belongs to anti-neoplastic drugs Pomahope 3mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 3mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 3mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 3mg is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 3mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope 3mg capsules has three primary pharmacological activ...

POMAHOPE 2MG ANTI-ANGIOGENESIS DESCRIPTION Pomalidomide is sold under the brand name Pomahope 2mg and it belongs to anti-neoplastic drugs Pomahope 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 2mg is used by combining with dexamethasone. Pomahope 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activit...

POMAHOPE 1MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg is used by combining with dexamethasone. P omahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope 1mg capsules has three primary pharmacological ac...